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ABSTRACT 
Anesthesia providers have the cardinal responsibility to ensure that patient safety is 
maintained throughout the perioperative period. Neuromuscular blocking drugs are frequently 
administered to patients during surgery. Residual weakness at the end of surgery can place 
patients at risk for critical respiratory events. There are several ways to monitor a patient for 
recovery of neuromuscular function. The definition of recovery is defined as a Train-of-four ratio 
greater than 0.9 and can only be assessed using a quantitative peripheral nerve stimulator. The 
aim of this project was to increase knowledge and utilization regarding the use of quantitative 
monitors to assess neuromuscular function. Train-of-four (TOF) is the most widely used means 
of nerve stimulation assessment by delivering four equal stimuli; a comparison is made of the 
four responses (Nagelhout, 2014). When partial paralysis is present a fade in response occurs 
from twitch one to twitch four; the difference in twitch response is used to calculate the train-of-
four ratio (TOFR) (Nagelhout, 2014). Anesthesia providers (n = 80) at two student clinical 
rotation sites in Maricopa County Arizona were sent a pretest survey, educational presentation, 
and posttest survey to compare knowledge and attitudes, awareness of techniques, and practice 
habits regarding neuromuscular monitoring; the final number of respondents was 12. The results 
of this project concluded that most providers assess neuromuscular function using a conventional 
peripheral nerve stimulator (n = 11). After reviewing the educational presentation, most 
anesthesia providers agreed that postoperative residual paralysis/weakness is a problem (n = 10) 
and the best method to assess neuromuscular function recovery and to guide reversal agent 
administration is to use a quantitative nerve stimulator (n = 9). Many providers (n = 7) stated 
they were unlikely to change their practice and cited inadequate resources as a barrier (n = 9). In 
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conclusion, quantitative monitoring for neuromuscular function recovery may feasibly become 
the new standard of care with further education and access to the resources necessary to 
accomplish that. 
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INTRODUCTION 
Background 
Nondepolarizing neuromuscular blocking drugs (NMBD) are used in the operating room 
for a variety of surgical procedures when muscle relaxation is crucial to patient safety. 
Incomplete recovery from the effects of these medications occur in as many as 40% of cases and 
patients are susceptible to developing respiratory complications such as hypoxemia, 
hypoventilation, airway obstruction, and apnea (Kiekkas, Bakalis, Stefanopoulos, Konstantinou, 
& Aretha, 2014). Critical respiratory events place the patient at risk for prolonged recovery, re-
intubation, pneumonia, hemodynamic instability, and unexpected admission to the intensive care 
unit (ICU) (Kiekkas et al., 2014). Incomplete recovery from neuromuscular blockade is defined 
as a train-of-four ratio (TOFR) less than 0.9 (Lien & Kopman, 2014). Currently, peripheral nerve 
stimulators are the gold standard used to obtain a train-of-four (TOF) reading. The most widely 
used peripheral nerve stimulator provides qualitative data that relies on the examiners subjective 
visual or tactile assessment of the patient’s muscle response to the stimulus to determine the 
presence or absence of fade by comparing the size of the fourth twitch to the size of the first 
twitch. There is a risk of variability in assessment between examiners. Most examiners are 
unable to detect fade through subjective assessment when the TOFR reaches 0.4 (Brull & 
Kopman, 2017). A TOFR of 0.7 is associated with significant weakness (Lien & Kopman, 2014). 
Peripheral nerve stimulators that use acceleromyography technology quantitatively measure the 
muscle response to TOF stimulation (Lien & Kopman, 2014) and are reported to assist providers 
more reliably prevent residual neuromuscular paralysis. Acceleromyography monitoring is 
accomplished by attaching a piezoelectric sensor at the thumb and measures the rate of angular 
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acceleration in response to nerve stimulation, the size of the acceleration output is quantified into 
a TOFR (Dilos & Eisenkraft, 2014). The goal is to accomplish a TOFR of greater that 0.9 as a 
determinate of full recovery of neuromuscular function. Small degrees of residual neuromuscular 
relaxation, defined as a TOFR between 0.8 and 0.9, impairs the ability to swallow and increases 
the risk of pulmonary aspiration (Unterbuchner, 2018).  
Key Concepts 
The key concepts of this project are to provide education to anesthesia providers 
regarding the use quantitative peripheral nerve stimulators to influence practice change in 
monitoring for depth of neuromuscular blockade with the administration of non-depolarizing 
neuromuscular blocking drugs.  
Peripheral Nerve Stimulator 
The peripheral nerve stimulator is a neuromuscular monitor that delivers a series of 
electric shocks or impulses through electrodes applied to the patient’s skin near a nerve 
(Nagelhout, 2014).  
Qualitative Nerve Stimulator 
A qualitative nerve stimulator permits a provider to assess the response to nerve 
stimulation by visual and tactile assessment;  
Quantitative Nerve Stimulator 
A quantitative nerve stimulator couples the stimulator to a displacement transducer that 
monitors movement with nerve stimulation and provides a quantifiable value known as a Train-
of-four ratio (Nagelhout, 2014). Acceleromyography (AMG) and kinemyography (KMG) are 
technologies that are used for quantitative neuromuscular monitoring.  
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Acceleromyography Technology 
Acceleromyography technology is employed by attaching a piezoelectric sensor the 
thumb and measures the rate of angular acceleration in response to nerve stimulation, the size of 
the acceleration output is quantified into a TOFR (Dilos & Eisenkraft, 2014).  
Kinemyography Technology 
Kinemyography technology utilizes a piezoelectric sensor strip that is incorporated into a 
U-shaped device, a mechanosensor, that is placed between the thumb and index finger (Dilos & 
Eisenkraft, 2014). Movement of the thumb in response to nerve stimulation produces a 
redistribution of electrical charge across the piezoelectric sensor, the voltage produced is 
measured and quantified as a TOFR (Dilos & Eisenkraft, 2014).  
Acceleromyography and kinemyography are reliably interchangeable to assess recovery 
of neuromuscular block (Ezer, Bezen, Saracoglu, Ozata, & Sengul, 2014).  
Nondepolarizing Neuromuscular Blocking Drugs 
Nondepolarizing neuromuscular blocking drugs bind to presynaptic and postsynaptic 
acetylcholine receptors. The binding of these drugs to presynaptic acetylcholine receptors 
prevents acetylcholine from being made available for release to sustain a muscle contraction with 
nerve stimulation (Naguib, 2015). These drugs can lead to intense muscle tone relaxation 
commonly referred to as paralysis. Muscle twitch depression results from the binding of NMBD 
to postsynaptic acetylcholine receptors (Naguib, 2015).  
Purpose, Aims and Objectives 
The purpose of this Doctor of Nursing Practice (DNP) project is to improve 
neuromuscular function assessment practices of anesthesia providers that are congruent with 
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current evidence-based practice. The aim is to increase knowledge and utilization regarding the 
use of a quantitative Train-of-four monitor for neuromuscular function recovery. The objective is 
to identify current evidence-based recommendations in the literature for the use of 
acceleromyography technology to assess neuromuscular function after patients have received 
nondepolarizing neuromuscular blocking drugs during surgery. 
The stakeholders for this project are the anesthesia department leaders and the anesthesia 
staff that chose to participate in the survey and educational presentation. Involuntary 
stakeholders are represented by the patients who require neuromuscular blockade for a surgical 
procedure. Patients will presumably benefit from a more reliable monitoring technique to assess 
neuromuscular function recovery that assures improved safety and reduces the occurrence of 
critical respiratory events in the perioperative period.  
Project Question 
How do anesthesia providers (P) participating in an educational presentation regarding 
the use of acceleromyography technology (I) perceive they will change their neuromuscular 
monitoring attitudes and practices (O) following the presentation (T)?  
Theory and Framework 
Theory of Planned Behavior 
The Theory of Planned Behavior suggests that behavior change is influenced by attitude, 
subjective norms, perceived behavioral control, and behavioral intention (Cornally, 2014). 
Attitudes result from beliefs about the consequences of a behavior and evaluation of the outcome 
(Cornally, 2014). The target population for this project, anesthesia providers, may have existing 
attitudes regarding current practice and not perceive a problem and need for change. Subjective 
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norms relate to an individual’s motivation to comply with the beliefs of others (Cornally, 2014). 
The influence of other providers may encourage or prohibit changes in assessment practices. 
Perceived behavioral control pertains to an individual's beliefs to carry out a behavior and 
encompasses internal (knowledge and ability) and external (tangible obstacles and opportunities) 
factors (Cornally, 2014). Behavior intention is predicted by attitudes, subjective norms, and 
perceived behavioral control (Cornally, 2014). This theory was chosen because it involves 
components of provider behavior that influence practice change. 
 
 
 
 
 
 
FIGURE 1. Theory of planned behavior model. 
Promoting Action on Research Implementation in Health Services 
The conceptual framework to operationalize this project is the Promoting Action on 
Research Implementation in Health Services (PARIHS). The PARIHS framework is used to 
understand the complex process on how evidence is used for successful implementation into 
practice with the implicit assumption that relevant research will result in improved outcomes for 
patients and organizations (Rycroft-Malone, 2013). The framework encompasses three elements: 
evidence, context, and facilitation. Evidence must be scientifically robust and align with provider 
Attitude 
Social 
Norms 
Perceived 
Control 
Intention Behavior 
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and patient preferences; context refers to an environment where culture and leadership are 
receptive to change where there are appropriate monitoring and feedback systems are in place; 
facilitation of change requires input from skilled external and internal facilitators (Rycroft-
Malone, 2013). 
Evidence is generated from research, clinical experience, provider experience and local 
context applicability (Rycroft-Malone, 2013). Research evidence must be well conceived, 
valued, and relevant to the audience (Rycroft-Malone, 2013). Research in the realm of clinical 
experience must reflect upon the experience and expertise of the audience, and consensus within 
the group on the relevance and importance of the evidence is essential (Rycroft-Malone, 2013). 
The local context or organization must value the research as relevant and reflect upon its 
importance and applicability to practice (Rycroft-Malone, 2013). Most anesthesia providers are 
unfamiliar with acceleromyography technology and likewise unaware that traditional qualitative 
peripheral nerve stimulators do not provide an accurate assessment of recovery from 
neuromuscular paralysis. A thorough search of relevant research will be conducted and 
synthesized on the topic of acceleromyography use, with a focus on meta-analyses, systematic 
reviews, and randomized controlled trials. Additionally, research regarding current attitudes and 
practice habits regarding monitoring for neuromuscular paralysis will be included in the 
synthesis of evidence. This type of evidence is relevant to the audience as anesthesia providers 
monitor for neuromuscular paralysis daily and will ideally be valued as a patient safety concern, 
Patient safety is of great concern and value to every organization or local context where 
anesthesia services are provided. Anesthesia providers participating this DNP project study will 
be presented with this high-quality evidence in the form of an educational presentation.  
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Context is defined in terms of culture, leadership, and evaluation. Culture involves 
defining values, beliefs, and norms, the organization should promote learning and innovation, 
and there should be consistency between provider roles and experience to the value of 
implementing research into action (Rycroft-Malone, 2013). Leadership will focus on effective 
teamwork, the organizational structure, and an enabling approach to learning, teaching, and 
managing (Rycroft-Malone, 2013). Evaluation involves feedback on individual, team, and 
system performance using multiple methods such as clinical performance, economic outcomes, 
and provider experience with the proposed change (Rycroft-Malone, 2013). The education will 
be presented to anesthesia providers at facilities receptive to learning the benefits of this newer 
technology. The goal would be to obtain interest and agreement that acceleromyography is a 
superior technology for assessment and ultimately lead to a change in culture and practice habits. 
After the education is delivered to this audience, data regarding changes in attitudes and beliefs 
about the use of acceleromyography monitors will be analyzed to predict the success of 
implementing this change into practice. 
Facilitation focuses on the purpose, roles, skills, and attributes of all individuals involved 
in the proposed practice change (Rycroft-Malone, 2013). The facilitator is a student registered 
nurse anesthetist that will foster credibility in the material being presented. The participants will 
be anesthesia providers willing to participate in the educational presentation. The information 
will be presented as power point presentation that will be recorded to allow for flexibility in 
attendance and participation. 
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FIGURE 2. Adaptation of PARIHS framework. 
Synthesis of Evidence 
A literature review was conducted through electronic databases PubMED, and CINAHL. 
The search terms that were used included acceleromyography, anesthesia, neuromuscular 
blockade, Train-of-four monitoring, and postoperative paralysis. The search yielded 143 articles. 
Ten articles were used for the synthesis of evidence and were chosen based on their relevance to 
acceleromyography monitoring, current practice behaviors and attitudes, and studies conducted 
within the last 10 years (Appendix A). Meta-analyses, systematic reviews, and randomized 
controlled trials were preferentially selected due to the high level of evidence that they provide.  
Acceleromyography (AMG) monitoring has been shown to accurately detect the presence 
of residual neuromuscular paralysis that has the potential to result in critical respiratory events in 
the postoperative period (Bhananker, 2015; Murphy et al., 2011; Murphy et al., 2008; Piccioni, 
2014; Sauer, Stahn, Soltesz, Noeldge-Schomburg, & Mencke, 2011). There is wide variability in 
the current assessment practices of anesthesia providers when neuromuscular blocking drugs 
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(NMBD) are administered; qualitative assessment of Train-of-four (TOF) response using a 
conventional peripheral nerve stimulator (PNS), quantitative peripheral nerve stimulators (rare), 
and physical assessment of neuromuscular function using clinical criteria as the sole evaluation 
(Naguib et al., 2010; Naguib, Kopman, & Ensor, 2007; Videira & Vieira, 2011). The inadequacy 
of conventional PNS and physical assessment criteria in detecting adequate recovery from 
neuromuscular blockade frequently results in clinically significant residual paralysis, and 
inadequate dosing, timing, or omission of reversal agent administration (Bhananker, 2015; 
Fortier et al., 2015; Murphy et al., 2011; Murphy et al., 2008; Naguib et al., 2007; Pietraszewski 
& Gaszynski, 2013; Sauer et al., 2011). Studies that implicate that the use of PNS do not 
decrease the incidence of residual paralysis in the postoperative period had similar themes that 
threaten their credibility. The conduct of anesthesia was not kept constant, choice of drugs 
varied, and the use of peripheral nerve stimulators was not consistent even to guide the dosing of 
muscle relaxant, and antagonism of neuromuscular blockade was often attempted at a significant 
degree of paralysis (Nauguib et. al, 2007). The use of uncalibrated AMG monitoring may 
overestimate the train-of-four ratio (TOFR) but patients have consistently greater levels of 
neuromuscular recovery when these monitors are used when compared to qualitative assessment 
using conventional PNS and clinical criteria (Murphy et al., 2008). The current practice habits of 
anesthesia providers reflect a lack of awareness of the incidence and severity of postoperative 
residual paralysis (PORP) and the placement of minimal value on the use of neuromuscular 
monitoring devices (Naguib et al., 2010; Naguib et al., 2007). Clinicians guide the administration 
of reversal agents or omit them all together based on criteria that is not quantifiable (total dose of 
NMBD, timing since last dose of NMBD, absence of fade when using a PNS, and clinical 
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criteria) often resulting in unacceptable levels of PORP (Fortier, 2015; Murphy et al., 2011; 
Murphy et al., 2008; Naguib et al., 2007; Naguib et al., 2010; Videira & Vieira, 2011).  
Strengths, Weaknesses and Gaps 
The strength of appraised literature is that 50% of the evidence was derived from one 
meta-analysis and four randomized controlled trials. The overall findings of this evidence 
synthesis prove that quantitative peripheral nerve stimulators are superior to the current practice 
norms using subjective assessment of a patient’s physical status with or without traditional 
peripheral nerve stimulators. Another strength is that multiple studies derived that many 
providers are unaware of the problem of residual neuromuscular paralysis thus making this DNP 
project important to create awareness and influence practice change. The weaknesses to the 
evidence include the lack of a systematic review or meta-analysis within the last ten years, over 
half of the studies were conducted outside the United States, and the providers in some of the 
studies were not blinded to the study group; this may pose a threat to the validity and reliability 
of the evidence. One of the gaps is the limited availability and use of quantitative monitor that 
use AMG technology in current practice. Quantitative monitors are not readily available in the 
United States and when these monitors are accessible, anesthesia providers often opt to use the 
conventional PNS (Naguib et al., 2010). The results of a survey evaluating management of 
neuromuscular blockade suggest that anesthesia providers have variable opinions regarding the 
best way to assess for neuromuscular function recovery (Naguib et al., 2010). Some 90% of U.S. 
survey respondents agreed that the TOFR should be greater than 80% prior to extubation 
(Naguib et al., 2010). In contrast, 70% of U.S. respondents believed that the ability to sustain a 
five second head lift is a reliable indicator of neuromuscular recovery (Naguib et al., 2010). It is 
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prudent to hypothesize that this may be due to a lack of training on their use or gap in education 
on the benefits of using quantitative monitoring. The Anesthesia Patient Safety Foundation 
Collaborative Panel on Neuromuscular Blockade and Patient Safety recommend the use of 
quantitative monitoring should be used when neuromuscular blocking drugs are administered, 
and these monitors should be available at all facilities where anesthesia care is delivered 
(Murphy, 2018). 
METHODS 
Design 
This project was conducted using a pretest email survey (Appendix B), followed by an 
educational PowerPoint presentation (Appendix C) and posttest (Appendix D). Project material 
was sent to anesthesia providers by the head of the anesthesia department at each facility that 
participated. Potential participants were sent a recruitment email, disclosure form, links to the 
pretest/posttest surveys, and the PowerPoint presentation. The PowerPoint presentation included 
information about the incidence of PORP, current practice standards, monitoring techniques, 
current practice habits, benefits of quantitative monitoring, and reversal agent administration. 
The entire length of the presentation was 18 slides including the title and reference slides. The 
pretest and posttest survey each had seven questions. The use of email allowed for a larger 
sample size from multiple diverse facilities. This DNP project compared knowledge and 
attitudes, awareness of techniques, and practice habits regarding neuromuscular monitoring in 
the perioperative period before and after receiving an educational training on the use of 
quantitative peripheral nerve stimulators. This design does not require randomization or a control 
group and is capable of measuring change in health-related outcomes after an intervention 
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(Rouen, 2017). The pretest/posttest was appropriate to assess how the intervention will influence 
caregiver attitudes and behaviors.  
Setting 
This project was implemented at two University of Arizona affiliated medical centers in 
Maricopa County, Arizona. 
Participants 
A convenience sample of 80 anesthesia providers with the title of physician 
anesthesiologist, certified registered nurse anesthetists (CRNA), and student registered nurse 
anesthetists (SRNA) were the participants for this project. The final number of participants was 
12 and consisted of all CRNA providers.  
Data Collection 
Approval from the Institutional Review Board (IRB) at the University of Arizona was 
obtained and met the requirements for minimal risk research (Appendix G). Data was collected 
using a pretest/posttest method. The survey period started on April 15, 2019 and closed on April 
21, 2019. Participants were asked about their current practice habits, perceived incidence of 
residual neuromuscular paralysis, opinions on monitoring methods, and reversal agent 
administration practices. This was accomplished using multiple-choice and Likert scale type 
questions for a total of seven questions for each survey. The Likert scale questions were five-
point scale questions ranging from strongly agree to strongly disagree for the perceived 
incidence of PORP and very likely to very unlikely for the likelihood to change future practice 
habits. The posttest included the same questions about current practice habits, perceived 
incidence of residual neuromuscular paralysis, opinions on monitoring methods, and reversal 
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agent administration practices. All points of data collection were obtained immediately before 
and after the intervention. Data regarding role as an anesthesia provider and years of experience 
was collected for demographic purposes. The posttest included questions that evaluated the 
participants’ likelihood to change their practice, if needed, and to assess any barriers to practice 
change. 
Ethical Considerations 
This project did not involve patients or vulnerable populations. Respect for persons was 
addressed by allowing participant autonomy and respect of their privacy. Participation in the 
educational information was voluntary. Informed consent was obtained, and pre-test and post-
test data will be anonymous. The fundamental principle of beneficence is “do no harm” 
(Department of Health, Education & Welfare, 1979). Beneficence was addressed in the very 
nature of this project by improving patient safety with a more accurate way to monitor patients 
for residual neuromuscular paralysis to guide anesthesia providers’ care of patients. There were 
no risks involved with participating in an educational training. Justice was maintained by 
allowing voluntary participation in the educational training and the recruitment of anesthesia 
providers to participate may indirectly benefit patients through improved safety. 
Data Analysis 
Data was analyzed using the Statistical Package for the Social Sciences (SPSS) software 
using the Wilcoxon signed rank test. The Wilcoxon signed rank test is used to compare two sets 
of scores from the same participant; it investigates a change in score from one point in time to 
another after an intervention has taken place (Laerd Statistics, 2018). Descriptive statistics 
quantitatively describe the key features of collected data, it aims to summarize the actual sample 
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being studied, and does not require a control for comparison (Kellar & Kelvin, 2013). This type 
of analysis is helpful to compare changes in knowledge, attitudes towards quantitative 
monitoring, and perceived changes in practice habits.  
RESULTS 
Demographics 
Project materials were sent to 80 anesthesia providers at two University of Arizona nurse 
anesthesia clinical sites by the anesthesia department directors at each facility and resulted in a 
15% response rate (n = 12). The pretest, educational materials, and posttest were intended to be 
sent to any qualified anesthesia provider with the title CRNA, physician anesthesiologist, and/or 
SRNA. The final sample consisted of only CRNA participants with experience in providing 
anesthesia care that ranged from less than one year to greater than 20 years (Figure 3).  
 
FIGURE 3. Years of experience of respondents. 
Responses to Specific Project Questions 
Respondents were asked five questions for comparison before and after an educational 
presentation on neuromuscular function assessment practices. These five questions examined 
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methods used for assessment, perceptions of best practice methods, presence of postoperative 
residual paralysis/weakness, and reversal agent administration practices. The posttest included 
questions regarding the respondent’s likelihood the change their practice habits and perceived 
barriers to practice change.  
Project Question 1 
Which method do you use to determine status of neuromuscular blockade? Respondents 
cited conventional nerve stimulators as the most frequently sited method (n = 11) in both the 
pretest and posttest (Figure 4). There was no difference between samples.  
 
FIGURE 4. Respondents methods of determining status of neuromuscular blockade. 
Project Question 2 
Which method do you feel is the best to monitor for paralysis/weakness? There was no 
significant difference in pretest and posttest scores (Z = 1.089, p = .276). However, examination 
of the raw data revealed that fewer respondents selected physical assessment criteria as the best 
method to monitor for paralysis/weakness after reviewing the educational material (Figure 5).  
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FIGURE 5. Respondents perception of the best method of neuromuscular assessment. 
Project Question 3 
Is postoperative paralysis/weakness a problem? Respondents were asked to answer a 
Likert scale question regarding their perceptions of whether postoperative residual paralysis is a 
problem; responses ranged from strongly disagree to strongly agree. There was a significant 
difference between pretest and posttest data (Z = 2.27, p = 0.023). The pretest revealed that 
multiple respondents strongly disagreed, disagreed, or neither agreed nor disagreed that 
postoperative residual paralysis/weakness was a problem. The posttest results showed 
respondents mostly agreed or strongly agreed that postoperative residual paralysis/weakness is a 
problem (Figure 6). The Wilcoxon Signed Rank test indicated that the posttest ranks were 
statistically and significantly higher than the pretest ranks in favor of respondents strongly 
agreeing that postoperative residual paralysis/weakness is a problem.  
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FIGURE 6. Respondents perception of postoperative residual paralysis/weakness. 
Project Question 4 
What site do you feel is best to monitor peripheral nerve response for recovery from 
neuromuscular blockade? The pretest and posttest data were unchanged, and all respondents 
chose the ulnar nerve as the best site to monitor for recovery of neuromuscular function when 
using a peripheral nerve stimulator.  
Project Question 5 
What rationale do you believe is the most reliable method for determining if you need to 
administer or can omit a reversal agent? A statistically significant difference was found between 
pretest and posttest data (Z = 2.00, p = 0.046), respondents favored train-of-four ratio as the best 
method to guide reversal agent administration or omission after the educational presentation. 
Prior to reviewing the educational presentation, 41.7% of respondents (n = 5) believed that 
physical assessment criteria were the most reliable method to determine dosing or omission of 
reversal agents for neuromuscular blockade; 41.7% (n=5) selected train-of-four ratio using an 
acceleromyographic monitor as the most reliable method. The posttest responses revealed that 
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only 8.3% (n = 1) of respondents believed that physical assessment criteria were reliable for 
reversal agent administration or omission; 75% (n = 9) stated that quantitative, Train-of-four 
ratio data was the most reliable method (Figure 7).  
 
FIGURE 7. Respondents rationale for administration or omission of reversal agents 
Project Question 6 
How likely are you to change your practice habits in the future? Most participants 
responded that they were very unlikely (n = 1), likely (n = 1), or neutral (n = 5) when asked 
about their intent to change their practice habits. Participants that responded that they were likely 
to change their practice represented 41.67% of the sample (n = 5).  
Project Question 7 
What barriers do you perceive in changing your practice? Inadequate resources were 
cited most frequently as the barrier to changing practice (n = 9). Some respondents also believed 
that postoperative residual paralysis/weakness was not a problem at their facility and stated this 
was a barrier to changing their practice (n = 3).  
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DISCUSSION 
Relationship of Results to Project Aims, Theory and Framework 
The aim of this project was to increase knowledge and utilization regarding the use of a 
quantitative monitor for neuromuscular function recovery. This goal was partially accomplished 
by gaining participation in the presented project material and obtaining data that revealed 
significant changes in respondent’s perception of the presence of postoperative residual 
paralysis/weakness, and the most reliable method of determining if a reversal agent should be 
administered or omitted. Posttest scores that were not statistically significant still indicated a 
change in belief that physical assessment criteria are not as reliable as using some form of a 
peripheral nerve stimulator to monitor for paralysis/weakness. Increasing the use of quantitative 
monitors as an additional aim of this project was more difficult to accomplish as the two 
facilities where this project was presented do not have access to quantitative monitors to 
neuromuscular function and this was the most frequently cited barrier to practice change. The 
Theory of Planned Behavior suggests that behavioral intention is predicted by attitudes, 
subjective norms, and perceived behavioral control. Most respondents reported neutral or likely 
to change their practice habits and that barriers to practice change were inadequate resources. 
The lack of resources is an external factor in a persons’ perceived control to carry out a behavior, 
in this case, a practice change. The PARIHS framework encompasses three elements: evidence, 
context, and facilitation. The evidence that was presented was evidence based, applicable to 
practice, and congruent with the clinical experience of most providers. The context of the project 
material was relevant to anesthesia practice, and the proposed change fit with organization. 
However, facilitation would prove to be difficult due to lack of resources and provider attitudes 
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about the proposed change. There were respondents that still believed that physical assessment 
criteria and qualitative peripheral nerve stimulators were superior to quantitative monitoring to 
assess neuromuscular function and some that even believed that postoperative residual 
paralysis/weakness was not a problem.  
Impact of Results on Practice Change 
The results of this project proved that there was agreement that quantitative monitoring is 
a superior method to assess for neuromuscular function recovery when compared to subjective 
criteria such as physical assessment parameters and conventional peripheral nerve stimulators. 
However, inadequate resources and provider attitudes toward change may present as barriers to 
sustainability of practice change. Some respondents still strongly disagreed that postoperative 
residual paralysis was a problem and stated that they were unlikely to change their practice in the 
future. One of the clinical sites that participated in this survey administers Sugammadex 
regularly for reversal of neuromuscular blockade and this may be a possible reason to believe 
that postoperative paralysis is not a significant problem and why practice change may not be 
achieved. Sugammadex is a selective paralytic drug binding agent that is able to reverse a 
shallow or profound aminosteroid induced neuromuscular blockade to a TOFR greater than 0.9 
within three minutes (Naguib, 2015).  
Strengths and Limitations 
Strengths of this project include the flexibility for participation, project materials were 
sent electronically, and participants could review the material and respond at time convenient for 
them. The total participation time was less than 30 minutes. 
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Limitations of this project were the smaller sample size, a total of 12 responses were able 
to be used for analysis. There was only a one-week timeframe allotted for participation. The 
project material was sent to two facilities that do not have access to quantitative peripheral nerve 
stimulators; data from facilities that have access to both conventional and quantitative monitors 
may have provided valuable information regarding providers practice habits and attitudes when 
assessing neuromuscular function recovery. The length of the project did not allow to assess for 
actual changes in practice. 
Dissemination and Implications for Future Practice 
The project was presented at the Arizona Association of Nurse Anesthetists Sun and Fun 
conference March of 2019 except for the results as the project was not complete. The results of 
the project will be shared by means of an executive summary (Appendix H) with the two 
facilities where the material was presented. Implications for future practice would be to influence 
practice change by gaining stakeholder interest in a more effective method for monitoring 
neuromuscular function recovery and ideally lead to the use of quantitative monitoring at these 
facilities.  
DNP Essentials 
The DNP essentials that have been met are essentials I, II, III, and VIII.  
DNP essential I is the application of scientific underpinnings to practice. This essential 
was met by synthesizing evidence-based research and applying it to practice by educating 
anesthesia providers about neuromuscular monitoring techniques. The Theory of Planned 
Behavior and the PARIHS framework were the scientific underpinnings used to apply this 
project to practice.  
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DNP essential II is the application of organizational and systems leadership for quality 
improvement and systems thinking. This essential was met by collaborating with the anesthesia 
department leadership at two clinical sites to disseminate my project materials to improve 
neuromuscular assessment practices of anesthesia providers.  
DNP essential III is the application of clinical scholarship and analytical methods for 
evidence-based practice. This essential was met by synthesizing evidence-based research to 
prepare a scholarly educational presentation about neuromuscular monitoring practices in 
anesthesia care.  
DNP essential VIII is the application of advanced practice competencies. This essential 
was met by discovering a problematic issue with observed anesthesia practices in the clinical 
setting and then disseminating information regarding advanced health assessment techniques in 
the field of anesthesia.  
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APPENDIX A: 
APPRAISAL OF EVIDENCE 
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Meta-Analysis 
Studies Evidence Supporting Hypothesis Counterevidence Against Hypothesis Conclusions 
Naguib et al. (2007) 
 
Hypothesis: Intraoperative 
neuromuscular monitoring 
reduces the incidence of 
postoperative residual 
paralysis (PORP) 
Studies using qualitative peripheral nerve 
stimulators (PNS) 
 
 Shorten et al. (1995) 
a. Recovery was greater after administration of 
neuromuscular blocking drugs (NMBD) 
when Train-of-four (TOF) monitoring was 
used 
 Fruergaard et al. (1998) 
a. TOF ratio (TOFR) was significantly higher 
in the monitored group after tracheal 
extubation compared to clinical criteria 
alone 
 Ueda et al. (1991) 
a. Intraoperative assessment of neuromuscular 
blockade using tactile evaluation of TOF 
response was higher compared to those 
assessed using clinical criteria alone 
Studies using quantitative peripheral nerve 
stimulators 
 
 Mortensen et al. (1995) 
a. TOFR was higher in the monitored group 
using acceleromyograhy (AMG) at the time 
of reversal 
 Gatke et al. (2002) 
a. Residual block can be minimized using 
AMG monitoring 
 Baillard et al. (2005) 
a. After departmental education on the use of 
AMG monitoring, the use of this type of 
monitoring rose from 2% to 60%; the use of 
reversal agents rose from 6% to 42%; the 
incidence of PORP decreased from 62% to 
< 4% 
 
Studies using qualitative peripheral nerve 
stimulators 
 
 Pedersen et al. (1990) 
a. The use of a PNS had no effect on 
the PORP 
 Fawcett et al. (1995) 
a. PORP was not decreased when 
PNS were used 
 Hayes et al. (2001) 
a. The use of intermediate acting 
NMBDs does not decrease PORP 
b. PORP was not significantly less 
when PNS were used 
 McCaul et al. (2002) 
a. The use of PNS did not lead to 
adequate recovery at time of 
tracheal extubation 
 The use of PNS can guide the provider on 
incremental dosing of NMBDs, 
appropriateness of recovery and 
subsequent tracheal extubation 
 Clinical criteria alone are inferior to the 
use of PNS in assessing the degree of 
neuromuscular blockade 
 Multiple studies identified an attempt to 
reverse a profound block by using just a 
TOF count instead of a TOFR, which can 
only reliably be obtained using a 
quantitative PNS 
 Multiple studies that negate the hypothesis 
did not have a constant method of 
anesthesia delivery including the choice of 
NMBDs, the use of monitors (even when 
made available to all clinicians), and no 
mention of a clinical decision-making 
protocol regarding monitoring or reversal 
 The meta-analysis is greater than 10 years 
old and does not specifically evaluate 
quantitative monitoring 
Randomized Controlled Trial 
Studies Evidence Supporting Hypothesis Counterevidence Against Hypothesis Conclusions 
Piccioni et al. (2014) 
 
 There was not a complete stabilization period 
for AMG calibration; the sample size was 
 Maximum inspiratory pressure (MIP) 
& maximum expiratory pressure 
 AMG TOFR of 1.0 excludes NMBD 
induced respiratory muscle weakness; 
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Hypothesis: If clinically 
relevant residual 
concentration of 
rocuronium is present at an 
AMG TOFR of 1.0, 
administration of 
sugammadex will improve 
respiratory muscle function 
 
small; respiratory tests were performed twice 
(three times is the recommendation) 
 
(MEP) did not improve after 
sugammadex administration when 
compared to placebo concluding that 
if respiratory muscle weakness was 
attributable to NMBDs, sugammadex 
would improve these measurements 
 
limited amount of studies to replicate this 
finding; small sample size (n = 20) 
 
Murphy et al. (2011) 
 
Hypothesis: AMG 
monitoring will reduce the 
number of patients with a 
TOFR < 0.9 and associated 
symptoms of PORP 
 
 The incidence of patients with TOFR < 0.9 is 
significantly lower in the AMG group 
compared to those monitored with a 
conventional qualitative PNS 
 Patients monitored with AMG have 
significantly less overall weakness and 
symptoms of muscle weakness 
 
 AMG monitoring is more accurate 
with calibration prior to NMBD 
administration 
a. TOFR are likely reflected as higher 
with a single post anesthesia 
measurement in this study 
 
 AMG monitoring proves to be superior to 
qualitative PNS in detecting PORP 
 Despite patients having a normal subjective 
assessment of qualitative measures, patients 
that did not receive reversal agents had more 
critical respiratory events 
 The use of subjective assessment measures 
is not a reliable indicator of PORP 
 
Sauer et al. (2011) 
 
Hypothesis: Patients with 
PORP will have a higher 
incidence of critical 
respiratory events, n = 114, 
P < 0.05 
 
 39.5% of patients extubated with a TOFR < 
1.0 had significantly more critical respiratory 
events, defined as an arterial oxygen saturation 
of < 93%, when compared to those with a 
TOFR of 1.0 (P = 0.021) 
 Patients were randomized to a placebo group 
or neostigmine reversal group  
a. The trachea was extubated at a TOFR of 1.0 
in the neostigmine group 
b. The average TOFR at the time of tracheal 
extubation in the placebo group was 0.7 (P < 
0.001) 
 Patients in the control and placebo group had 
normal responses to qualitative TOF 
stimulation and double burst stimulation 
(DBS), defined as a lack of fade, and 
additionally an AMG TOFR < 1.0 prior to 
randomization at the end of surgery after a 
NMBD was administered 
a. In the absence of a subjective fade with 
qualitative TOF stimulation and DBS, a 
clinician cannot distinguish a TOFR 
consistent with PORP (TOFR < 1.0) 
 AMG monitors were calibrated prior to 
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administration of NMBDs 
 
Murphy et al. (2008) 
 
Hypothesis: The use of 
AMG monitoring reduces 
the risk of PORP and the 
incidence adverse 
respiratory events in the 
post anesthesia care unit 
(PACU), n = 179, P < 0.01 
 A significantly lower number of patients 
presented to PACU with PORP when 
monitored with AMG than those monitored 
with qualitative TOF monitoring, 4.5% and 
30% respectively (P < 0.0001) 
 A significantly higher incidence of severe 
PORP was present in the qualitative TOF 
group compared to the AMG group, 13.3% 
and 0% respectively (P < 0.001) 
  Patients in the qualitative TOF group 
developed more episodes of severe hypoxemia, 
defined as a pulse oximetry of < 90%, and 
occurrences of airway obstruction, 21.1% and 
11.1% respectively compared to the AMG 
group that had 0% for both measures (P < 
0.002) 
 The incidence, severity, and duration of 
hypoxemia within the first 30 minutes in 
PACU were significantly less in the AMG 
group (P < 0.0001) 
 
 The current standard to quantify 
residual block is mechanomyography 
(MMG) and AMG values are not 
interchangeable 
a. An uncalibrated AMG TOFR of 
0.97 corresponds to a MMG value 
of 0.9 
 AMG values were monitored in the 
PACU in an awake patient which may 
have reduced the accuracy of the 
reading 
 Quantitative neuromuscular monitoring is 
superior to subjective qualitative measures 
 Even though an uncalibrated AMG monitor 
can produce a false high TOF reading, 
patients have a TOFR < 0.9 less frequently 
when AMG monitoring is used and the risk 
of developing critical respiratory events is 
also reduced 
 
Cohort Studies 
Bhananker et al. (2015) 
 
Comparison of TOF count 
by anesthesia providers 
versus count using TOF-
Watch SX (AMG monitor), 
n = 75, 687 observations 
collected 
 
 There was agreement between provider 
subjective assessment and TOF-Watch SX 
56% of the time (386 observations) 
a. Of these agreements, 87% were at TOF 
counts of 0 and 4 
 At TOF counts of 1, 2, and 3 the agreement 
was only 36% (409 observations) 
a. Provider subjective assessment revealed a 
higher TOF count in 96% of these 
disagreements (254 observations) and a 
lower TOF count in 4% (10 observations) 
 Dosing and timing guidelines for reversal of 
NMBDs is based on TOF count from an AMG 
monitor which concludes that subjective 
assessment of TOF count may result in 
inadequate dosing or inappropriate timing of 
reversal agents 
 
 TOF-Watch SX was used without 
calibration 
 
 There is a frequent lack of concordance 
between a provider’s subjective assessment 
and quantitative assessment 
a. Subjective assessment often over 
estimates recovery from paralysis 
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Fortier et al. (2015) 
 
Investigation of the 
incidence and severity of 
PORP defined as a TOFR < 
0.9 at tracheal extubation 
and at arrival to PACU 
 
 Anesthesia providers were permitted to assess 
the degree of neuromuscular block using 
qualitative TOF monitors or clinical criteria 
only 
 Patients were assessed for this study using the 
TOF-Watch (AMG monitor) and all 
anesthesiologists and nurses were blinded to 
the values 
 The incidence of PORP at tracheal extubation 
was 63.5% and 56.5% at arrival to PACU (all 
results falling within the 95% confidence 
interval) 
 Qualitative TOF monitors were not used with 
every patient 
a. There was a slightly lower incidence with 
qualitative monitor used 51.1% vs 67.1% 
 
 The TOF-Watch was not calibrated 
before neuromuscular block was 
administered 
 The use of reversal agent did not 
result in a reduction in the incidence 
of PORP 
 
 The conduct of anesthesia was not 
standardized 
 Patients continued to have PORP at time of 
tracheal extubation and arrival to PACU 
despite assessment of qualitative measures 
 Some clinicians do not use qualitative TOF 
monitors suggesting that they may not find 
value in their use 
 
Pietraszewski et al. (2013) 
 
Observation of the 
incidence PORP in elderly 
patients after general 
anesthesia and rocuronium 
administration, n = 415, P 
< 0.05 
 Patients were considered recovered from 
neuromuscular block based on clinical 
indicators alone (5 second head lift, sustained 
firm hand grip or tongue protrusion, and 
effective cough) 
 Neuromuscular monitoring was prohibited 
intraoperatively 
 Patients did not receive a reversal agent and 
were only allowed to recover spontaneously 
 TOFR < 0.7 was present in 31% of all patients 
(P < 0.05), most frequently in those 65 years 
old or older, 44% in that age group. TOFR was 
monitored using an AMG monitor  
 17.9% of patients 65 or older and 8.2% of 
patients < 65 years old experienced hypoxemia 
and required ventilation support (P < 0.05) 
 
  Clinical criteria alone are inadequate in 
detecting PORP 
 Neuromuscular monitoring is obligatory 
 The use of reversal agents is prudent and 
best guided by an accurate assessment of 
TOFR 
Survey 
Videira et al. (2011) 
 
Evaluation of what rules of 
thumb clinicians use to 
decide whether to 
antagonize nondepolarizing 
NMBDs at a hospital in 
 The most frequently used rules of thumb used 
for administering a reversal agent were a short 
interval of time since the last NMBD was 
administered and the presence of an inadequate 
breathing pattern, 73% and 71% respectively 
 Clinicians considered the presence of PORP to 
be higher in their colleagues practice as 
  This is a relatively small sample and it is 
representative of practices in developing 
country where technology may not be as 
readily available 
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Brazil, n = 86 
 
compared to their own 
 The hospital’s PORP was estimated to 41% 
based on an evaluation of 61 patients using 
AMG monitoring 
 
Naguib et al. (2010) 
 
Evaluation to determine 
attitudes about and the use 
of NMBDs and 
neuromuscular monitors 
amongst anesthesia 
practitioners in the United 
States and Europe 
 More U. S. respondents reported never 
observing PORP after administering NMBDs 
than European respondents, 88.1% vs 78.6% 
 More U. S. respondents estimated the 
incidence of clinically significant PORP as < 
1% than European respondents, 64.1% vs 
52.2% 
 U. S. and European respondents similarly 
responded that PORP is a significant anesthetic 
complication 
 The majority of U. S. and European 
respondents believe that the routine use of any 
type of TOF monitor would decrease the 
incidence of PORP (80% and 85% 
respectively) 
 European respondents reported that they had 
more access to quantitative TOF monitors than 
their U. S. counterparts, 70.2% vs 22.7% 
a. Monitors were more likely to be available 1 
per operating room in Europe 
b. 77.3% of U. S. respondents reported that 
quantitative monitors are not available in 
their department 
 When both quantitative and qualitative 
monitors are available, European clinicians 
were more likely to use quantitative 
monitoring (53.2% vs 18.8%). U. S. clinicians 
were more likely to use qualitative monitors 
(63.2% vs 17.1%) 
 Respondents from both the U. S. and Europe 
agreed that sustained response to sustained 
tetany does not exclude residual 
neuromuscular weakness (78.5% and 77.7% 
respectively) 
 More respondents from the U. S. reported that 
clinical signs are reliable indicators of 
adequate neuromuscular recovery than their 
  The problem of PORP is reported as a 
significant clinical complication but 
respondents seem to far underestimate its 
occurrence 
 Despite the results that 80% of U. S. 
respondents believe the use of some type of 
TOF monitor would decrease the incidence 
of PORP; 68.2% of the U. S. respondents 
reported that clinical signs are indicators of 
adequate neuromuscular recovery 
 Most clinicians cannot detect fade once the 
TOFR reaches 40% when using subjective 
tactile assessment (Brull, 2017) 
a. 78.9% of U.S. respondents believe the 
TOFR should be > 90% prior to tracheal 
extubation. This can only reliably be 
measured using a quantitative TOF 
monitor 
 Quantitative TOF monitors are not readily 
available in the U. S.  
a. When given the option between a 
quantitative and qualitative monitor, U. S. 
respondents still opt to use qualitative 
monitors. This could be due to an 
availability issue where there are not 
quantitative monitors in each operating 
room or possible a lack of education on 
their value or training on their use.  
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European counterparts (68.2% vs 43.5%) 
 More U. S. respondents reported that the 
TOFR should be in the 91-100% range before 
tracheal extubation when compared to 
European respondents (78.9% vs 57.1%) 
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APPENDIX B: 
PRETEST SURVEY 
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1. How many years have you practiced anesthesia? 
a. 0-5 years 
b. 6-10 years 
c. 11-20 years 
d. > 20 years 
2. What is your role? 
a. CRNA 
b. Anesthesiologist physician 
c. SRNA 
3. Which method do you currently use to determine status of neuromuscular blockade? 
a. Conventional nerve stimulator 
b. Quantitative nerve stimulator – Stim pod or acceleromyography 
c. Physical assessment criteria – head lift, hand squeeze, tidal volume & respiratory rate 
4. Which method do you feel is the best to monitor for paralysis/weakness? 
a. Physical assessment 
b. Qualitative peripheral nerve stimulator using a conventional nerve stimulator 
c. Quantitative peripheral nerve stimulator using acceleromyography 
5. Is post-operative paralysis/weakness a problem? 
a. Strongly disagree 
b. Disagree 
c. Neutral 
d. Agree 
e. Strongly agree 
6. What site do you feel is best to monitor peripheral nerve response for recovery from 
neuromuscular blockade? 
a. Facial nerve 
b. Ulnar Nerve 
c. Neither 
7. What rationale do you believe is the MOST reliable method for determining if you need 
to administer or can omit reversal agents? 
a. Train-of-four twitch count 
b. Timing since last neuromuscular blocking drug 
c. Physical assessment criteria - head lift, hand squeeze, TV & respiratory rate 
d. Train-of-four ratio using an acceleromyographic quantitative monitor 
e. Administration of Sugammadex 
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APPENDIX C: 
EDUCATIONAL POWERPOINT PRESENTATION 
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APPENDIX D: 
POSTTEST SURVEY 
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1. Which method do you currently use to determine status of neuromuscular blockade? 
a. Conventional nerve stimulator 
b. Quantitative nerve stimulator – Stim pod or acceleromyography 
c. Physical assessment criteria – head lift, hand squeeze, TV & respiratory rate 
2. Which method do you feel is the best to monitor for paralysis/weakness? 
a. Physical assessment 
b. Qualitative peripheral nerve stimulator using a conventional nerve stimulator 
c. Quantitative peripheral nerve stimulator using acceleromyography 
3. Is post-operative paralysis/weakness a problem? 
a. Strongly disagree 
b. Disagree 
c. Neutral 
d. Agree 
e. Strongly agree 
4. What site do you feel is best to monitor peripheral nerve response for recovery from 
neuromuscular blockade? 
a. Facial nerve 
b. Ulnar Nerve 
c. Neither 
5. What rationale do you believe is the MOST reliable method for determining if you need 
to administer or can omit reversal agents? 
a. Train-of-four twitch count 
b. Timing since last neuromuscular blocking drug 
c. Physical assessment criteria - head lift, hand squeeze, TV & respiratory rate 
d. Train-of-four ratio using an acceleromyographic quantitative monitor 
e. Administration of Sugammadex 
6. How likely are you to change your practice habits in the future? 
a. Very Unlikely 
b. Unlikely 
c. Neutral 
d. Likely 
e. Very Likely 
7. What barriers do you perceive in changing your practice? 
a. Resources are inadequate 
b. Lack of support from organization or staff 
c. Evidence is lacking to support the change 
d. Residual paralysis is not a problem at my facility 
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APPENDIX E: 
RECRUITMENT EMAIL 
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Dear Participant, 
 
You are being asked to participate in a project regarding neuromuscular function assessment 
practices. Agreement to participate will involve a brief seven question pretest using Qualtrics, 
followed by a narrated PowerPoint presentation, and conclude with a seven question posttest 
using Qualtrics.  
An Institutional Review Board responsible for human subjects’ research at The University of 
Arizona reviewed this research project and found it to be acceptable, according to applicable 
state and federal regulations and University policies designed to protect the rights and welfare of 
participants in research. 
I would greatly appreciate your participation. 
If you chose to participate in this project, it will take no longer than 30 minutes of your time. I 
have attached a disclosure form that explains your rights as a participant and expectations of 
participation. I have outlined below the sequence of attached documents for your review in the 
order that they are intended to be reviewed. 
1. Disclosure form 
2. Link to pretest 
3. PowerPoint Presentation 
4. Link to posttest 
Please feel free to contact me with any questions, my contact information is provided below. 
 
Sincerely, 
Diana Willis 
Primary Investigator 
Doctorate of Nursing Practice Candidate 
University of Arizona 
Phone: (602)571-4863 
email: dianamiller@email.arizona.edu 
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APPENDIX F: 
DISCLOSURE FORM 
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University of Arizona 
Disclosure Form 
 
Project Title: Anesthesia Providers’ Knowledge and Utilization of a Quantitative Monitor for 
Assessment of Neuromuscular Function Recovery 
Principal Investigator Name: Diana Willis  
The purpose of this project is to improve neuromuscular function assessment practices of 
anesthesia providers after administration of neuromuscular blocking drugs that are congruent 
with current evidence-based practice. 
 
An Institutional Review Board responsible for human subjects’ research at The University of 
Arizona reviewed this research project and found it to be acceptable, according to applicable 
state and federal regulations and University policies designed to protect the rights and welfare of 
participants in research. 
 
If you choose to take part in this project, you will be asked to complete a brief seven question 
pretest followed immediately by a brief narrated PowerPoint presentation and a seven question 
posttest, to be completed immediately after the presentation. I am inquiring about your opinions 
regarding postoperative residual paralysis, the current practice habits you employ to monitor 
neuromuscular function and antagonize neuromuscular blockade. I would greatly appreciate your 
participation and feedback in this project. 
 
 It will take approximately 30 minutes to complete the pretest, presentation, & posttest.  
 You will not be compensated for your participation in this project 
 There are no foreseeable risks associated with participating in this project 
 You will receive the benefit of improved knowledge of neuromuscular monitoring 
techniques from your participation 
 Survey responses are anonymous 
 Participation is voluntary 
 Refusal to participate will involve no penalty or loss of benefits to which you are 
otherwise entitled  
 You may withdraw at any time from the project 
 You may skip any question that you choose not to answer 
 By participating, you do not give up any personal legal rights you may have as a 
participant in this 
 
For questions, concerns, or complaints about the project, you may call Diana Willis, University 
of Arizona Doctorate of Nursing Practice Candidate, at (602)571-4863 &/or 
dianamiller@email.arizona.edu 
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For questions about your rights as a participant in this study or to discuss other study-related 
concerns or complaints with someone who is not part of the research team, you may contact the 
Human Subjects Protection Program at 520-626-6721 or online 
at http://rgw.arizona.edu/compliance/human-subjects-protection-program. 
 
By submitting your surveys, you are consenting to allow your responses to be used for the 
purposes of this project. 
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APPENDIX G: 
THE UNIVERSITY OF ARIZONA INSTITUTIONAL REVIEW BOARD APPROVAL 
LETTER 
 
  
 
 
53 
  
 
 
54 
 
  
 
 
55 
APPENDIX H: 
EXECUTIVE SUMMARY 
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Executive Summary 
Anesthesia Providers’ Knowledge and Utilization of a Quantitative Monitor for Assessment 
of Neuromuscular Function Recovery 
Prepared by Diana Willis BSN, RN, SRNA 
 
Introduction 
This document summarizes the results of the project I conducted at your facility.  
Objective 
The purpose of this project was to improve neuromuscular function assessment practices of 
anesthesia providers that are congruent with current evidence-based practice. The aim was to 
increase knowledge and utilization regarding the use of a quantitative monitor for neuromuscular 
function recovery 
Conclusion (Findings) 
After participating in my educational presentation, anesthesia providers (CRNAs) agreed that 
postoperative residual paralysis/weakness was a patient safety issue and that quantitative 
monitoring is the best method to monitor the status of neuromuscular function. Quantitative 
monitoring is felt to be the most reliable method for determining if a reversal agent needs to be 
administered or omitted. The most commonly cited barrier to changing practice was that 
resources are inadequate (access to equipment/monitors). 
Background 
Incomplete recovery from the effects of neuromuscular blocking drugs occur in as many as 40% 
of cases and patients are susceptible to developing respiratory complications such as hypoxemia, 
hypoventilation, airway obstruction, and apnea. Residual paralysis/weakness is defined as a 
Train-of-four ratio of less than 0.9 and can only be reliable assessed with a quantitative monitor. 
Subjective assessment with a conventional nerve stimulator or physical assessment carries the 
risk of variability between providers and place patients at risk. 
Process 
Participants were asked to complete a pretest, review an educational presentation, and complete a 
posttest. The pretest and posttest included questions about neuromuscular function assessment 
practices (method, site, and reversal agents) and if postoperative paralysis was thought to be a 
problem. 
Recommendations 
My recommendations would be to incorporate quantitative monitoring into the standard of care 
for patients requiring muscle relaxation for surgery. The ability to quantify neuromuscular 
function will enable anesthesia providers to more safely care for patients in their care, ensuring 
that they have adequate function to prevent adverse events postoperatively. 
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